Stereotactic Radiosurgery for Patients With Hepatic Metastases.
Completed · Phase 1
Conditions studied: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating patients with liver metastases.
Key facts
- Study ID
- NCT00547677
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 27
- Starts
- 2004-07-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2019-02-15
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.